Furthermore, studies on highly lung-metastatic breast cancer cell lines, where reduced expression of miR-18a-5p correlates with concomitant overexpression of SREBP1, have demonstrated that SREBP1 is a direct target of miR-18a-5p (Zhang et al., 2019). This evidence concerns the gene SREBF1 and breast carcinoma.